Medications
FDA approves Biogen's MS drug Plegridy
Biogen Idec says that federal regulators have approved the specialty drugmaker's new treatment for people with relapsing forms of multiple sclerosis.
Aug 16, 2014
0
0
Multiple Sclerosis
Neuroscience
Gene that controls nerve conduction velocity linked to multiple sclerosis
A new study published in The American Journal of Pathology identifies a novel gene that controls nerve conduction velocity. Investigators report that even minor reductions in conduction velocity may aggravate disease in multiple ...
Aug 13, 2014
0
0
Immunology
'Worm pill' could ease autoimmune disease symptoms
(Medical Xpress)—Experts believe a molecule in parasitic worms could help explain why worm infections can effectively treat a range of autoimmune diseases, including multiple sclerosis, psoriasis, rheumatoid arthritis and ...
Aug 11, 2014
2
0
Medications
Dimethyl fumarate for MS: Added benefit is not proven
Dimethyl fumarate (trade name: Tecfidera) has been approved since January 2014 for adults with relapsing remitting multiple sclerosis (RRMS). In an early benefit assessment pursuant to the Act on the Reform of the Market ...
Aug 7, 2014
0
0
Immunology
Is the gut microbiome a potential cause and therapeutic target for autoimmune diseases like multiple sclerosis?
Numerous risk factors are believed to contribute to the development of autoimmune disorders such as multiple sclerosis, and new research is focusing on the role that bacteria in the gastrointestinal tract as well as other ...
Aug 7, 2014
0
1
Medical research
Scientists 1 step closer to cell therapy for multiple sclerosis patients
Scientists at The New York Stem Cell Foundation (NYSCF) Research Institute are one step closer to creating a viable cell replacement therapy for multiple sclerosis from a patient's own cells.
Jul 24, 2014
0
0
Immunology
Researchers discover neuroprotective role of immune cell
A type of immune cell widely believed to exacerbate chronic adult brain diseases, such as Alzheimer's disease and multiple sclerosis (MS), can actually protect the brain from traumatic brain injury (TBI) and may slow the ...
Jul 22, 2014
0
0
Neuroscience
Researchers publish one of the longest longitudinal studies of cognition in multiple sclerosis
Researchers at Kessler Foundation and the Cleveland Clinic have published one of the longest longitudinal studies of cognition in multiple sclerosis (MS). The article, "Cognitive impairment in multiple sclerosis: An 18-year ...
Jun 24, 2014
0
0
Genetics
Parasitic worms of pigs could provide new treatments of human diseases
(Medical Xpress)—New treatments for inflammatory bowel disease, rheumatoid arthritis, multiple sclerosis, diabetes and autism could be on the horizon, after a global University of Melbourne – lead study successfully mapped ...
Jun 16, 2014
0
0
Neuroscience
International committee re-defines how multiple sclerosis is described and understood
Multiple sclerosis manifests itself in many different ways and different courses. A recent effort to fine-tune descriptions – or phenotypes—of MS was undertaken by an international team of leaders in MS research and clinical ...
Jun 4, 2014
0
0
